TBTC Study 28: evaluation of a moxifloxacin-based, isoniazid-sparing regimen for tuberculosis treatment

Trial Profile

TBTC Study 28: evaluation of a moxifloxacin-based, isoniazid-sparing regimen for tuberculosis treatment

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Aug 2011

At a glance

  • Drugs Ethambutol; Isoniazid; Moxifloxacin; Pyrazinamide; Pyridoxine; Rifampicin
  • Indications Pulmonary tuberculosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Aug 2009 Results have been reported in the American Journal of Respiratory and Critical Care Medicine.
    • 20 Sep 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top